Quick Answer
Clearside Biomedical, Inc. reported Net Income of -$34.35 million for fiscal year 2024.
Clearside Biomedical, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$34.35M | -5.7% |
| 2023 | -$32.48M | +1.4% |
| 2022 | -$32.95M | -8862.5% |
| 2021 | $376.0K | +102.1% |
| 2020 | -$18.21M | +40.8% |
| 2019 | -$30.77M | +62.8% |
| 2018 | -$82.82M | -40.4% |
| 2017 | -$58.98M | -127.9% |
| 2016 | -$25.88M | -46.7% |
| 2015 | -$17.64M | -73.1% |
| 2014 | -$10.19M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$5.97M | +22.3% | -32.9% |
| June 30, 2025 | -$4.50M | +40.8% | +45.3% |
| March 31, 2025 | -$8.22M | +30.1% | -7.0% |
| September 30, 2024 | -$7.69M | +17.0% | -1.2% |
| June 30, 2024 | -$7.59M | +16.6% | +35.4% |
| March 31, 2024 | -$11.76M | -26.8% | -26.9% |
| September 30, 2023 | -$9.27M | -18.4% | -1.8% |
| June 30, 2023 | -$9.11M | -16.5% | +1.9% |
- Clearside Biomedical, Inc. showed a decrease of -5.7% in Net Income compared to the prior fiscal year.
- Over the 2014–2024 period, Clearside Biomedical, Inc.’s net income has declined by 237.1% (from -$10.19 million to -$34.35 million).
- The most recent figure is from Clearside Biomedical, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: